Zhang Z, Su J, Xue J, Xiao L, Hong L, Cai G
Int J Mol Sci. 2024; 25(19).
PMID: 39409016
PMC: 11476760.
DOI: 10.3390/ijms251910687.
Jeddi F, Faghfuri E, Mehranfar S, Soozangar N
Cancer Cell Int. 2024; 24(1):240.
PMID: 38982390
PMC: 11234524.
DOI: 10.1186/s12935-024-03405-2.
Zhang J, Sheng H, Hu C, Li F, Cai B, Ma Y
Int J Mol Sci. 2023; 24(15).
PMID: 37569258
PMC: 10419045.
DOI: 10.3390/ijms241511882.
Chinnappan R, Mir T, Alsalameh S, Makhzoum T, Alzhrani A, Alnajjar K
Cancers (Basel). 2023; 15(13).
PMID: 37444523
PMC: 10341261.
DOI: 10.3390/cancers15133414.
Tost J
Adv Exp Med Biol. 2022; 1389:395-469.
PMID: 36350519
DOI: 10.1007/978-3-031-11454-0_16.
Optical bio-sensing of DNA methylation analysis: an overview of recent progress and future prospects.
Adampourezare M, Hasanzadeh M, Seidi F
RSC Adv. 2022; 12(39):25786-25806.
PMID: 36199327
PMC: 9460980.
DOI: 10.1039/d2ra03630d.
Analysis of FOXP3 DNA Methylation Patterns to Identify Functional FOXP3+ T-Cell Subpopulations.
Minskaia E, Lacerda J
Methods Mol Biol. 2022; 2559:115-136.
PMID: 36180630
DOI: 10.1007/978-1-0716-2647-4_9.
Mechanisms of DNA Methylation in Virus-Host Interaction in Hepatitis B Infection: Pathogenesis and Oncogenetic Properties.
Zhang D, Guo S, Schrodi S
Int J Mol Sci. 2021; 22(18).
PMID: 34576022
PMC: 8466338.
DOI: 10.3390/ijms22189858.
DNA Methylation in Solid Tumors: Functions and Methods of Detection.
Martisova A, Holcakova J, Izadi N, Sebuyoya R, Hrstka R, Bartosik M
Int J Mol Sci. 2021; 22(8).
PMID: 33921911
PMC: 8073724.
DOI: 10.3390/ijms22084247.
SIMON: Simple methods for analyzing DNA methylation by targeted bisulfite next-generation sequencing.
Vial-Pradel S, Hasegawa Y, Nakagawa A, Miyaki S, Machida Y, Kojima S
Plant Biotechnol (Tokyo). 2020; 36(4):213-222.
PMID: 31983875
PMC: 6978500.
DOI: 10.5511/plantbiotechnology.19.0822a.
N-acetylcysteine reverses the decrease of DNA methylation status caused by engineered gold, silicon, and chitosan nanoparticles.
Sooklert K, Nilyai S, Rojanathanes R, Jindatip D, Sae-Liang N, Kitkumthorn N
Int J Nanomedicine. 2019; 14:4573-4587.
PMID: 31296987
PMC: 6599212.
DOI: 10.2147/IJN.S204372.
DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies.
Larsen L, Lind G, Guldberg P, Dahl C
Int J Mol Sci. 2019; 20(11).
PMID: 31151158
PMC: 6600406.
DOI: 10.3390/ijms20112657.
A novel restriction endonuclease GlaI for rapid and highly sensitive detection of DNA methylation coupled with isothermal exponential amplification reaction.
Sun Y, Sun Y, Tian W, Liu C, Gao K, Li Z
Chem Sci. 2018; 9(5):1344-1351.
PMID: 29675182
PMC: 5887237.
DOI: 10.1039/c7sc04975g.
Highly sensitive and multiplexed analysis of CpG methylation at single-base resolution with ligation-based exponential amplification.
Su F, Wang L, Sun Y, Liu C, Duan X, Li Z
Chem Sci. 2017; 6(3):1866-1872.
PMID: 28706642
PMC: 5494546.
DOI: 10.1039/c4sc03135k.
MicroRNA-148a represents an independent prognostic marker in bladder cancer.
Ma L, Xu Z, Xu C, Jiang X
Tumour Biol. 2015; 37(6):7915-20.
PMID: 26700670
DOI: 10.1007/s13277-015-4688-0.
A polymerase engineered for bisulfite sequencing.
Millar D, Christova Y, Holliger P
Nucleic Acids Res. 2015; 43(22):e155.
PMID: 26271989
PMC: 4678845.
DOI: 10.1093/nar/gkv798.
Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease.
Reis I, Ramachandran K, Speer C, Gordian E, Singal R
Br J Cancer. 2015; 113(3):460-8.
PMID: 26171936
PMC: 4522641.
DOI: 10.1038/bjc.2015.240.
Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.
Andrew A, Marsit C, Schned A, Seigne J, Kelsey K, Moore J
Int J Cancer. 2015; 137(5):1158-66.
PMID: 25556547
PMC: 4485975.
DOI: 10.1002/ijc.29413.
The Epigenome View: An Effort towards Non-Invasive Prenatal Diagnosis.
Papageorgiou E, Koumbaris G, Kypri E, Hadjidaniel M, Patsalis P
Genes (Basel). 2014; 5(2):310-29.
PMID: 24722507
PMC: 4094935.
DOI: 10.3390/genes5020310.
DNA methylation in ductal carcinoma in situ of the breast.
Pang J, Dobrovic A, Fox S
Breast Cancer Res. 2013; 15(3):206.
PMID: 23826974
PMC: 3707020.
DOI: 10.1186/bcr3420.